UT Tyler Fisch College of Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- UT Tyler Fisch College of Pharmacy's estimated annual revenue is currently $3.7M per year.
- UT Tyler Fisch College of Pharmacy's estimated revenue per employee is $152,250
Employee Data
- UT Tyler Fisch College of Pharmacy has 24 Employees.
- UT Tyler Fisch College of Pharmacy grew their employee count by 0% last year.
UT Tyler Fisch College of Pharmacy's People
Name | Title | Email/Phone |
---|
UT Tyler Fisch College of Pharmacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.5M | 119 | 16% | N/A | N/A |
#2 | $11.3M | 70 | N/A | N/A | N/A |
#3 | $2.1M | 13 | -19% | N/A | N/A |
#4 | $37.6M | 161 | 3% | N/A | N/A |
#5 | $3.5M | 23 | 0% | N/A | N/A |
#6 | $0.1M | 2 | 100% | N/A | N/A |
#7 | $52.9M | 228 | 3% | N/A | N/A |
#8 | $20.9M | 122 | 27% | N/A | N/A |
#9 | $17.8M | 99 | 10% | N/A | N/A |
#10 | $6.5M | 38 | 3% | N/A | N/A |
What Is UT Tyler Fisch College of Pharmacy?
The Ben and Maytee Fisch College of Pharmacy offers the Pharm.D. degree in a student-centered, innovative format prepares students to become exceptional pharmacists. The mission of the Fisch College of Pharmacy is to advance public health and wellness in East Texas and beyond through innovation and collaboration in pharmacy education, scholarship and advocacy. The vision of the Fisch College of Pharmacy is to be the preeminent college of pharmacy that fosters leaders in pharmacy practice, education, scholarship, and public service to care for rural and other underserved populations.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.7M | 24 | 0% | N/A |
#2 | $4M | 24 | -14% | N/A |
#3 | $7.3M | 24 | -8% | N/A |
#4 | $3.5M | 25 | 9% | N/A |
#5 | $9.5M | 26 | -4% | N/A |